Axinn Serves as Antitrust Counsel for UPMC in its Affiliation with Washington Health System
June 13, 2024
University of Pittsburgh Medical Center (UPMC), a world-renowned health care provider and insurer, announced on June 1, 2024 that it had completed its affiliation with Washington Health System, which will now be known as UPMC Washington. The affiliation will ensure continuing access to high quality healthcare for communities in southwestern Pennsylvania. Axinn supported UPMC in antitrust reviews by the Federal Trade Commission and the Pennsylvania Office of Attorney General.
The Axinn team was led by partners Rick Dagen, Lisl Dunlop, Leslie Overton, and counsel Carol Liu, and included Josh Jowdy, Laviana Alharmoosh, Tasneem Chowdhury, Duncan Weals, Aiger Saudabayeva, Geunyoung Kim, John Bogert, Ashley McConnell, and Jason Rylander, Tara Kramek, Mariam Mansoor.
About Axinn
Axinn combines the skills, experience, and dedication of the world’s largest firms with the focus, responsiveness, efficiency, and attention to client needs of the best boutiques. The firm was established in the late 1990s by lawyers from premier Wall Street firms with a common vision: provide the highest level of service and strategic acumen in antitrust, intellectual property, and high-stakes litigation. Axinn’s lawyers have served as lead or co-lead counsel on more than half a trillion dollars in transactions and, in the last 10 years alone, have handled more than 500 litigations.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Conspiracy Theories Newsletter, 2026 Edition
Byline Articles
Antitrust
Axinn Partners John Harkrider and Craig Minerva Win 2026 Concurrences Antitrust Writing Award
Awards & Recognitions
Antitrust
Axinn Wins Firm of the Year – Americas at 2026 Global Competition Review Awards
Awards & Recognitions
Antitrust
IPWatchdog Sixth Annual Live Conference
Speaking Engagement
Intellectual Property
Is Any Deal Safe From Review in the EU? Implications of the “Towercast” Judgment
Podcast
Antitrust
Axinn Antitrust Insight: HSR Overhaul: Out with the New, In with the Old
Axinn Viewpoints
Antitrust
The DOJ's Whistleblower Program and Leniency
Axinn Viewpoints
Antitrust
Squires Again Broadens Discretion for Post-Grant Proceedings
Axinn Viewpoints
Intellectual Property